Domov › Rakovina vaječníkov › Virginia › Arlington
Klinické štúdie Rakovina vaječníkov v meste Arlington, VA
46 štúdií pre Rakovina vaječníkov hľadá účastníkov v zariadeniach v meste Arlington a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- Inova Fair Oaks Hospital, Fairfax · 11 míľ odtiaľ
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Prebieha náborFáza 2
- Inova Fairfax Hospital, Falls Church · 4 míľ odtiaľ
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Prebieha náborFáza 1/2
- Research Site, Fairfax · 11 míľ odtiaľ
A Study of PHST001 in Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology - Virginia, Fairfax · 11 míľ odtiaľ
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Prebieha náborFáza 2
- Next Virginia /ID# 279684, Fairfax · 11 míľ odtiaľ
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Prebieha náborFáza 1
- Site 04, Fairfax · 11 míľ odtiaľ
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Prebieha náborFáza 1
- Next Virginia /ID# 278607, Fairfax · 11 míľ odtiaľ
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Prebieha náborFáza 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · 11 míľ odtiaľ
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Prebieha náborFáza 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
Study of AVZO-021 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 míľ odtiaľ
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Prebieha náborFáza 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · 11 míľ odtiaľ
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Prebieha náborFáza 1/2
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Prebieha náborFáza 3
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Prebieha náborFáza 2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Prebieha náborFáza 1/2
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- Next Oncology Virginia, Fairfax · 11 míľ odtiaľ
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Prebieha náborFáza 1
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Prebieha náborFáza 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · 11 míľ odtiaľ
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Prebieha náborFáza 1
- Inova Schar Cancer Institute, Falls Church · 4 míľ odtiaľ
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Prebieha náborFáza 1
- Normunity Investigational Site, Fairfax · 11 míľ odtiaľ
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Prebieha nábor
- Inova Fairfax Hospital, Falls Church · 4 míľ odtiaľ
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- Inova Fair Oaks Hospital, Fairfax · 11 míľ odtiaľ
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Clinical Trial Site, Fairfax · 11 míľ odtiaľ
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Prebieha náborFáza 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Prebieha náborFáza 2
- 522, Fairfax · 11 míľ odtiaľ
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 míľ odtiaľ
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- NEXT, Fairfax · 11 míľ odtiaľ
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Prebieha náborFáza 3
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Prebieha náborFáza 1
- Dren Investigational Site, Fairfax · 11 míľ odtiaľ
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Prebieha náborFáza 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Štúdie Rakovina vaječníkov v iných mestách
- Houston, TX89 štúdií
- New York City, NY69 štúdií
- Boston, MA61 štúdií
- Los Angeles, CA50 štúdií
- Nashville, TN49 štúdií
- Philadelphia, PA44 štúdií
- Columbus, OH39 štúdií
- St. Louis, MO38 štúdií
- Chicago, IL36 štúdií
- San Antonio, TX31 štúdií
- Cleveland, OH30 štúdií
- Pittsburgh, PA30 štúdií
Iné štúdie v Arlington
- Nemalobunkový karcinóm pľúc104 štúdií
- Metastatická rakovina53 štúdií
- Kolorektálny karcinóm52 štúdií
- Rakovina (všetky typy)48 štúdií
- Rakovina prsníka47 štúdií
- Rakovina pľúc41 štúdií
- Rakovina endometria39 štúdií
- Rakovina pankreasu33 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku26 štúdií
- Malobuněčný rakovina plic23 štúdií
- Rakovina žalúdka20 štúdií
- Trojnásobne negatívny karcinóm prsníka20 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.